Inhibitors of antigen presentation by MHC class II molecules
US8598312B2 · kind B2 · utility
6Cited by
11References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 15, 2012 |
| Grant date | Dec 3, 2013 |
| Priority date | — |
| Expiry date | Jun 15, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds, pharmaceutical compositions containing such compounds and methods for their use. In particular, the compounds of the invention are useful for the treatment or prevention of diseases associated with T cell proliferation such as autoimmune diseases and disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.